Law Firms Press Telix Investors as Jan. 9 Lead-Plaintiff Deadline Nears in Securities Suits

Investors face a Jan. 9 deadline to seek lead-plaintiff status over alleged losses tied to regulatory setbacks.

Overview

New notices from Hagens Berman, Levi & Korsinsky, Bronstein Gewirtz & Grossman, The Gross Law Firm, and the Law Offices of Frank R. Cruz urge Telix shareholders to come forward.
The complaints claim Telix overstated progress on prostate cancer therapeutic candidates and misrepresented the reliability of its third-party manufacturing and supply chain.
Filings cite a July SEC subpoena regarding development disclosures and an August FDA Complete Response Letter for Zircaix that referenced CMC issues and Form 483 observations at partner sites.
The putative class period spans February 21, 2025 through August 28, 2025, and the actions seek to recover damages for those who bought Telix securities during that window.
Hagens Berman notes Telix ADSs fell sharply, including a roughly 21% drop after the final regulatory disclosure, and the firm is inviting whistleblower tips.